Mendus AB
@mendus.com
Changing the course of cancer treatment - We harness the power of the body's immune system to keep tumor cells in check.
Mendus AB's Company Logos
Mendus AB's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#FDF3EE
Provincial Pink
253, 243, 238
20, 79, 96
0, 4, 6, 1
#619EAF
Hippie Blue
97, 158, 175
193, 33, 53
45, 10, 0, 31
#052C65
Deep Sapphire
5, 44, 101
216, 91, 21
95, 56, 0, 60
About Mendus AB
Mendus AB is a cutting-edge brand that specializes in developing revolutionary cell-based cancer therapies. With unparalleled expertise in allogeneic dendritic cell biology, Mendus aims to create off-the-shelf treatments for both solid and blood-borne tumors. Their innovative therapeutic approaches, including intratumoral priming and cancer relapse vaccination, are currently in Phase II clinical development.
By leveraging these complementary methods, Mendus seeks to enhance survival outcomes and improve the quality of life for a wide range of cancer patients. Based in Sweden and the Netherlands, Mendus is a publicly traded company listed on the Nasdaq Stockholm. Led by a distinguished management team, including CEO Erik Manting, CSO Alex Karlsson-Parra, CMO Jeroen Rovers, CFO Lotta Ferm, and CTO Leopold Bertea, Mendus boasts a talented group of individuals with extensive experience in the medical and biotechnology fields.
With their commitment to pioneering treatments and improving patient outcomes, Mendus is at the forefront of cancer research and innovation
Related Brands
Tags
Cellular immunotherapy
Active dendritic cell therapy
Immune-oncology
Acute myeloid leukemia therapy
Ovarian cancer immunotherapy
